Our commitment
- Ensure uninterrupted access to medicines in the Cypriot market
- Advocate early access to innovative medicines in Cyprus
- Provide accurate educational information on disease areas and treatments to healthcare providers
- Enforce the Code of Conduct so that prescription decisions are made on an ethical and patient-focused basis and ensure that pharmaceutical companies act in an ethical and professional manner
- Support that European objectives regarding high healthcare standards will be implemented in the Cyprus market.
As a member of the EU Family, KEFEA aims to:
- Promote competitiveness of European industry
- Create favorable conditions which will guarantee the industry’s continuous quest for better therapies
- Foster conditions that will enable the industry to meet the growing healthcare expectations of present and future generations
